全文获取类型
收费全文 | 45301篇 |
免费 | 4544篇 |
国内免费 | 1180篇 |
专业分类
耳鼻咽喉 | 226篇 |
儿科学 | 1770篇 |
妇产科学 | 395篇 |
基础医学 | 5594篇 |
口腔科学 | 938篇 |
临床医学 | 4765篇 |
内科学 | 10456篇 |
皮肤病学 | 1001篇 |
神经病学 | 2631篇 |
特种医学 | 719篇 |
外国民族医学 | 4篇 |
外科学 | 3336篇 |
综合类 | 6628篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 3185篇 |
眼科学 | 554篇 |
药学 | 4283篇 |
29篇 | |
中国医学 | 2992篇 |
肿瘤学 | 1514篇 |
出版年
2024年 | 248篇 |
2023年 | 1039篇 |
2022年 | 1617篇 |
2021年 | 2274篇 |
2020年 | 2133篇 |
2019年 | 1954篇 |
2018年 | 1894篇 |
2017年 | 1934篇 |
2016年 | 1975篇 |
2015年 | 1793篇 |
2014年 | 3244篇 |
2013年 | 3475篇 |
2012年 | 3019篇 |
2011年 | 3192篇 |
2010年 | 2403篇 |
2009年 | 2294篇 |
2008年 | 2203篇 |
2007年 | 2001篇 |
2006年 | 1726篇 |
2005年 | 1545篇 |
2004年 | 1218篇 |
2003年 | 969篇 |
2002年 | 833篇 |
2001年 | 737篇 |
2000年 | 603篇 |
1999年 | 522篇 |
1998年 | 479篇 |
1997年 | 386篇 |
1996年 | 377篇 |
1995年 | 296篇 |
1994年 | 264篇 |
1993年 | 248篇 |
1992年 | 250篇 |
1991年 | 197篇 |
1990年 | 175篇 |
1989年 | 157篇 |
1988年 | 135篇 |
1987年 | 135篇 |
1986年 | 126篇 |
1985年 | 173篇 |
1984年 | 135篇 |
1983年 | 109篇 |
1982年 | 110篇 |
1981年 | 84篇 |
1980年 | 79篇 |
1979年 | 62篇 |
1978年 | 44篇 |
1977年 | 39篇 |
1976年 | 41篇 |
1974年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
高奉浔 《中国人民解放军军医大学学报》1989,(1)
Eight cases of mesenchymal chondrosarcoma either of skeletal(5 cases) or extrasketetalorigin (3 cases) are reported. According to histopathological and diagnostic criteria,mesenchymal chondrosarcoma were classified into two types cartilage isiand cell type andundifierentiated small cell type It is believed that the application of this classification in the study ofmesenchymal chondrosarcoma is helptul the estimation of its malignancy and choice of treatmentas well al in the prediction of its prognosis. Mesenchymal chondrosarcoma is a highly malignant neoplasm with poor prognosis. None ofthe patients in this series survived more than five years after they were diagnosed. The diffentialdiagnosis of malignant lymphoma, chondrosarcoma, hemangiopericytosarcoma, etc. was discussed.My data support the assumption that mesenchymal chondrosarcoma originates from the secondarymesenchyme rather than the primary mesenchyme. 相似文献
102.
103.
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy. 总被引:7,自引:0,他引:7
Peter Jacobsen Steen Andersen Kasper Rossing Birgitte V Hansen Hans-Henrik Parving 《Nephrology, dialysis, transplantation》2002,17(6):1019-1024
BACKGROUND: Albuminuria and hypertension are predictors of poor renal and cardiovascular outcome in patients with diabetes. Approximately 30% of type 1 patients with diabetic nephropathy (DN) have albuminuria >1 g/day, and blood pressure >135 and/or >85 mmHg despite antihypertensive therapy with recommended doses of ACE inhibitor (ACEI) and diuretics. We tested the effect of dual blockade of the renin-angiotensin system (RAS) in these patients. METHODS: We performed a randomised double blind crossover trial with 2 months treatment with Irbesartan 300 mg o.d. and placebo added on top of previous antihypertensive treatment. We included 21 type 1 patients with DN responding insufficiently to ACEI and diuretics, as defined above. At the end of each treatment period, albuminuria, 24-h blood pressure and glomerular filtration rate (GFR) were measured. RESULTS: Addition of 300 mg Irbesartan to the patients' usual antihypertensive therapy induced a mean reduction in albuminuria of 37% (95% CI 20-49, P<0.001); from 1574 mg/24 h (95% CI 1162-2132) to 996 mg/24 h (95% CI 699-1419), a reduction in 24-h blood pressure of 8 mmHg systolic (95% CI -2 to 18) and 5 mmHg diastolic (95% CI 1-9) (P=0.11 and 0.01, respectively) (from placebo, mean (SE) 146 (4)/80 (2) mmHg). GFR remained unchanged. Serum potassium increased (mean 4.3 to 4.6 mmol/l, P=0.02). Intervention to reduce serum potassium was needed in two patients with GFR <35 ml/min/1.73 m(2). Otherwise the dual blockade with Irbesartan was safe and well tolerated. CONCLUSIONS: Dual blockade of the RAS may offer additional renal and cardiovascular protection in type 1 patients with DN responding insufficiently to conventional antihypertensive therapy, including recommended doses of ACEI and diuretics. 相似文献
104.
【目的】研究拉米夫定对HBsAg阳性孕妇的乙肝病毒 (HBV)宫内阻断作用。【方法】拉米夫定组 43例 ,孕 2 8周起口服拉米夫定 ,每天 10 0mg至产后 30d。对照组 5 2例 ,未予用药。两组孕妇均于孕 2 8周、分娩前 ,其新生儿于生后 2 4h内免疫接种前抽静脉血检测HBsAg、HBeAg及HBV的定量。【结果】拉米夫定组孕妇HBV的DNA水平显著下降 (P <0 0 5 ) ,其新生儿宫内感染率 (16 3% )明显低于对照组 (32 7% ) ,P <0 0 5。两组孕妇及其新生儿未发现有不良反应。【结论】携带HBV孕妇产前服用拉米夫定可有效减少HBV宫内感染发生率。 相似文献
105.
目的探讨糜烂性胃炎(EG)在内镜下的形态、分布及预后.方法对1997年1月~2003年12月经内镜确诊的462例糜烂性胃炎进行分析.结果462例中,男性336例,女性126例,男女之比2.67:1.隆起糜烂型185例,占40.04%;平坦糜烂型277例,占59.96%.胃窦部363例,占总数的78.57%;其中隆起糜烂型173例,占47.66%;平坦糜烂型190例,占52.34%,两型之间差异无显著性(P>0.05).胃高位99例,占总数的21.43%;其中隆起糜烂型12例,占12.12%;平坦糜烂型87例,占87.88%;胃窦部隆起糜烂型占47.66%(173/363),胃高位隆起糜烂型占12.12%(12/99);隆起糜烂型和平坦糜烂型HP感染率分别为83.78%和27.08%,差异有非常显著性(χ2=142.68,P<0.01).结论胃窦部与胃高位糜烂性胃炎的发病率均以男性为主,其中隆起糜烂型好发于胃窦部,而胃高位以平坦糜烂型为主. 相似文献
106.
用放免法检测乙型慢性活动性肝炎病人的红细胞c3b受体(KBCCR1).结果:病人RBCCR1明显低于献血员(P<0.05);抗-HBs特异性免疫复合物阳性病人RBCCR1明显低于阴性病人(P<0.01),与红细胞C3b受体花环试验检测结果一致。表明乙型慢性活动性肝炎病人RBCCR1数量减少,活性下降。其原因可能是特异性循环免疫复合物占据了RBCCR1空位,使CR1活性下降。 相似文献
107.
The influence of partial gastrectomy on biochemical parameters of bone metabolism and bone density 总被引:2,自引:0,他引:2
Dr. H. Resch P. Pietschmann B. Pernecker E. Krexner R. Willvonseder 《Journal of molecular medicine (Berlin, Germany)》1992,70(5):426-429
Summary Since it has been suggested that gastric resections are followed by changes in bone metabolism, the aim of our study was to determine the biochemical parameters of bone metabolism and radial and lumbar bone density in 15 male ulcus patients treated by partial gastrectomy (Billroth II). Comparing the data with those of a corresponding control group, the lumbar bone density measured by quantitative computed tomography was statistically significantly lower (P < 0.04) in the patient group, whereas the peripheral bone mass of the distal part of the nondominant forearm measured by single-photon absorptiometry showed no statistically significant difference. In addition, a marked increase in alkaline phosphatase (P < 0.002) and urinary excretion of hydroxyproline (P < 0.003) was found in the gastrectomy group, whereas the 25-hydroxy-vitamin D levels were found to be significantly decreased (P < 0.04). Osteocalcin, a biochemical marker for osteoblast activity, and the carboxy-terminal propeptide of type I procollagen (PICP), a marker of collagen formation, were slightly but not significantly higher in gastrectomy-treated patients. The serum parathyroid hormone levels were similar in both groups. As none of the patients had any radiologic evidence of osteopenia, the changes in biochemical parameters of bone metabolism and bone mass in patients who had undergone partial gastrectomy could be a marker of latent bone loss.Abbreviations DPA/SPA
dual/single-photon absorptiometry
- BMD
bone mineral density
- QCT
quantitative computed tomography
- PICP
carboxy-terminal propeptide of type I procollagen
- 250HD3
25-hydroxy-vitamin D
- iPTH
parathyroid hormone
- OC
osteocalcin
- BMC
bone mineral content 相似文献
108.
109.
Soluble Fcγ-binding components were detected in gingival fluid from periodontal lesions by incubation with biotinylated human Fcγ fragments. FcγIII receptor was identified by incubation of gingival fluid with monoclonal antibody. Sodium dodecyl sulfate-polyacrylamide gel electophoresis and Western transfer showed that most of the Fcγ-binding components had minimal mobility in a 4–15% gradient gel under nonreducing conditions. Under reducing conditions, the main band of Fcγ-binding components in gingival fluid migrated corresponding to protein A of 49 kDa. The pattern of Fcγ-binding components was similar in serum and gingival fluid except for the observation in gingival fluid of Fcγ-binding components migrating like standard proteins of 19 to 20 kDa, a size that corresponds to the polypeptide part of FcγII receptor and FcγIII receptor. 相似文献
110.